Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

March 31, 2029

Study Completion Date

February 28, 2043

Conditions

Primary Hyperoxaluria Type 1 (PH1)

Interventions

DRUG

ABO-101

Intravenous (IV) infusion

Trial Locations (4)

COMPLETED

Nucleus Network, Saint Paul

RECRUITING

Mayo Clinic, Rochester

RECRUITING

Hospices Civils de Lyon- Hôpital Femmes Mères Enfants, Lyon

NOT_YET_RECRUITING

Kindernierenzentrum Bonn, Bonn